Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.
2.

Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily.

Iacono F, Prezioso D, Illiano E, Romeo G, Ruffo A, Amato B.

BMC Surg. 2012;12 Suppl 1:S23. doi: 10.1186/1471-2482-12-S1-S23. Epub 2012 Nov 15.

3.

Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.

Bertaccini A, Giampaoli M, Cividini R, Gattoni GL, Sanseverino R, Realfonso T, Napodano G, Fandella A, Guidoni E, Prezioso D, Galasso R, Cicalese C, Scattoni V, Armenio A, Conti G, Corinti M, Spasciani R, Liguori G, Lampropoulou N, Martorana G.

Arch Ital Urol Androl. 2012 Sep;84(3):117-22.

PMID:
23210402
4.

Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study.

Ryu YW, Lim SW, Kim JH, Ahn SH, Choi JD.

Urol Int. 2015;94(2):187-93. doi: 10.1159/000366521. Epub 2015 Jan 23.

PMID:
25614155
5.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
6.

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

MacDonald R, Tacklind JW, Rutks I, Wilt TJ.

BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2. Review.

7.

Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.

Giulianelli R, Pecoraro S, Sepe G, Leonardi R, Gentile BC, Albanesi L, Brunori S, Mavilla L, Pisanti F, Giannella R, Morello P, Tuzzolo D, Coscione M, Galasso F, D'Angelo T, Ferravante P, Morelli E, Miragliuolo A; Cooperative Ur.O.P Group.

Arch Ital Urol Androl. 2012 Jun;84(2):94-8.

PMID:
22908779
8.

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).

Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A, Blefari F, Carini M, Minervini A, Ginepri A, Salvia G, Vespasiani G, Santelli G, Cimino S, Allegro R, Collura Z, Fragalà E, Arnone S, Pareo RM.

Prostate. 2014 Nov;74(15):1471-80. doi: 10.1002/pros.22866. Epub 2014 Aug 23.

PMID:
25154739
9.

An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study.

Cai T, Morgia G, Carrieri G, Terrone C, Imbimbo C, Verze P, Mirone V; IDIProst® Gold Study Group.

Arch Ital Urol Androl. 2013 Dec 31;85(4):184-9. doi: 10.4081/aiua.2013.4.184.

11.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, MacDonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001423.

12.
13.

Serenoa repens for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R.

Cochrane Database Syst Rev. 2002;(3):CD001423. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001423.

PMID:
12137626
14.

Phytotherapy for benign prostatic hyperplasia.

Wilt TJ, Ishani A, Rutks I, MacDonald R.

Public Health Nutr. 2000 Dec;3(4A):459-72.

PMID:
11276294
15.

Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.

Morgia G, Mucciardi G, Galì A, Madonia M, Marchese F, Di Benedetto A, Romano G, Bonvissuto G, Castelli T, Macchione L, Magno C.

Urol Int. 2010;84(4):400-6. doi: 10.1159/000302716. Epub 2010 Mar 24.

PMID:
20332612
16.

Efficacy of a formulation containing Serenoa repens, Crocus sativus and Pinus massoniana extracts in men with concomitant LUTS and erectile dysfunction.

Quarto G, Cola A, Perdonà S.

Minerva Urol Nefrol. 2017 Jun;69(3):300-306. doi: 10.23736/S0393-2249.16.02661-8. Epub 2016 Sep 1.

18.

Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens.

Marzano R, Dinelli N, Ales V, Bertozzi MA.

Arch Ital Urol Androl. 2015 Mar 31;87(1):25-7. doi: 10.4081/aiua.2015.1.25.

19.

Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.

Alcaraz A, Carballido-Rodríguez J, Unda-Urzaiz M, Medina-López R, Ruiz-Cerdá JL, Rodríguez-Rubio F, García-Rojo D, Brenes-Bermúdez FJ, Cózar-Olmo JM, Baena-González V, Manasanch J.

Int Urol Nephrol. 2016 May;48(5):645-56. doi: 10.1007/s11255-015-1206-7. Epub 2016 Jan 25.

20.

Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Novara G, Giannarini G, Alcaraz A, Cózar-Olmo JM, Descazeaud A, Montorsi F, Ficarra V.

Eur Urol Focus. 2016 Dec;2(5):553-561. doi: 10.1016/j.euf.2016.04.002. Epub 2016 Apr 23. Review.

PMID:
28723522

Supplemental Content

Support Center